Events
Academy in Anaheim: optometry research, product, and innovations
American Academy of Optometry’s annual meeting highlights the latest clinical findings and product highlights.
Research
Antidepressant use worsens ocular surface health
Patients showed lower goblet cell density, weaker tear film stability, and more conjunctival epithelial damage—regardless of drug class
Research
Pilot study supports Rinsada for ocular surface allergen load reduction
Contralateral-eye comparison trial explores efficacy of the irrigating lid retractor for ocular lavage in symptomatic allergic conjunctivitis.
Pipeline
Kodiak's tarcocimab meets wet AMD phase 3 endpoint, targets Q4 BLA
Zenkuda and KSI-501 both met the primary endpoint in DAYBREAK study, accelerating Kodiak’s development plans.Events
Academy Optometry 2026 kicks off in Anaheim
American Academy of Optometry’s annual meeting opens on the West Coast with new formatting and a look ahead to 2027.
Research
CLI releases full Profitability Perspectives report on soft contact lens value
Newest See Tomorrow initiative offers an in-depth look at the first-ever analysis of CL profitability in the United States during AAOpt.
Products
Eyetamins by Optase target eyes prone to dryness with omega-7
Plant-based, softgel supplements are formulated to address long-term eye health with moisture balance support; upcoming AAO symposium dives deeper into the benefits.
Business
MyEyeDr to purchase EyeCare Partners' optometry division
Acquisition includes 300+ offices from top regional brands offering personalized eyecare and doctor-led service model; Q4 closing is expected.
Products
Sagent launches ready-to-use indocyanine green injection to US market
Optical imaging agent is reported to be the first FDA-approved ICG injection of its kind—with no reconstitution needed prior to use.
Pipeline
Beacon Therapeutics releases positive topline phase 2 data on laru-zova for XLRP
VISTA is reportedly the first pivotal trial in XLRP to achieve its FDA-endorsed primary endpoint; company plans to submit a rolling BLA later this year.
Products
FDA approves Rayner's RayOne Galaxy spiral IOL
Touted as the world’s first-ever spiralized IOL, the AI-developed platform is now commercially available across the United States.
Research
How accurate is ChatGPT in predicting FTMH surgery outcomes?
ChatGPT-5 matched, and sometimes beat, retina specialists at forecasting macular hole surgery outcomes, but its apparent edge came from a bias toward predicting success.
Events
The Empire Forum to unite retina science, industry, and investment
First-ever Empire Retina Forum to convene for one day only in NYC this fall.
Events
Registration open for Eyes On 2027
Largest virtual eyecare event of the year set for Nov. 6 and 7 with 8 hours of CE available for eyecare providers.
Products
Ray-Ban introduces new audio-only Meta AI glasses
Ray-Ban Meta Audio is the brand’s first AI glasses of its kind; company also debuts the next generation of Ray-Ban Meta (Gen 3).
Research
Tear biomarker test tied to accurate dry eye severity classification
Tear lymphotoxin-α (LTA) not only distinguishes dry eye severity but also identifies patients with significant symptoms—despite having little or no detectable ocular surface damage.
Products
Essilor unveils next-gen version of Nuance Audio smart glasses
Nuance Audio Plus features advanced hearing technology, an extended battery life, and capabilities for users to directly answer phone calls.
Research
Real-world analysis ties enVista Aspire IOL to functional intermediate vision
Outcomes largely mirrored previous clinical findings, with most eyes achieving strong distance vision alongside functional intermediate acuity.
Products
Customizable HOA-correcting optics now available for Ampleye scleral lenses
Art Optical’s prescribers can measure patient-specific visual distortion to create custom, wavefront-guided lenses for those with complex irregularities.
Pipeline